Overview


Linda Zeman advises clients on corporate law with a particular focus on private equity. She counsels clients on various corporate matters including add-on acquisitions, debt and equity investments, restructuring and sales. She has experience in a variety of industries including entertainment, energy, manufacturing and finance, and has previously advised on general corporate taxation. Linda has spent time in prominent international and domestic law firms both in the UK and Australia. Linda has contributed to various publications including the Australian Revenue Law Journal: Vol. 17: Issue 1 with her article titled “Federal Commissioner of Taxation v. Hart: Did the High Court set the Threshold too Low?”

Results


  • Represented an American multinational retailer on its acquisition of a leading care-at-home technology platform
  • Represented a leading Australian manufacturer and supplier of procedure packs and medical consumables for the public and private hospital markets on its first acquisition in the United Kingdom
  • Represented General Atlantic on its investment into Immunocore, a pioneering, clinical stage T cell receptor biotechnology company
  • Represented Praxair, Inc. in the EUR 5 billion divestment of the majority of Praxair’s businesses in Europe to Taiyo Nippon Sanso Corporation, a company listed on the Tokyo Stock Exchange and majority owned by Mitsubishi Chemical Holdings Corporation

Show More

Recognitions


  • The M&A Advisor, “M&A Deal of the Year” International M&A Award Winner, 2019
  • The Legal 500 UK 2020, recommended lawyer

Credentials


Education
University of Sydney, LLM, 2010
Australian National University, LLB, (Hons), 2006
Australian National University, BComm, 2005

Admissions
England and Wales
New South Wales, Australia

Show More